Peptide Synthesis IndustryThe global peptide synthesis market is poised for significant growth, with its valuation projected to increase from USD 520.0 million in 2023 to an impressive USD 1.1 billion ...

PolyPeptide Group / Key word (s): Expansion Doubling of production capacity at the manufacturing site in Malmö 08.01.2025 / 07:00 CET/CEST ...

Peptide Therapeutics MarketThe global peptide therapeutics market is on a strong growth trajectory, with sales projected to ...

As a wave of volatility has been re-introduced to the system, investors are flocking toward blue-chip companies for stability ...

Proposed acquisition adds Nimble's lead asset, an investigational oral peptide IL23R inhibitor in preclinical development for psoriasis, and a pipeline of other novel oral peptide assets across ...

The North Chicago, Ill., company said is also acquiring Nimble's peptide synthesis, screening and optimization platform, which uses proprietary technology to help drive rapid discovery and ...

Under the deal, the biotechnology company will acquire Nimble's lead asset, a pipeline of other novel oral peptide candidates, and peptide synthesis, screening, and optimization platform.

In addition to acquiring Nimble's drug candidates, AbbVie will gain access to the company's advanced peptide synthesis, screening, and optimization platform. Nimble's roots trace back to 1999 ...

AbbVie will also acquire Nimble's peptide synthesis platform, which is used to discover and optimize oral peptide therapeutics. Roche further taps drug discovery spinout's Nimble tech in $1.1B ...